Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its revolutionary Omnipod 5 Automated Insulin ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies.

Insulet (Nasdaq:PODD) announced today that SVP and Chief Technology Officer Mark Field is departing the company.

Insulet's Omnipod 5 device is the first such system ... to ease investor concerns about the potential hit on its insulin pump sales, given the soaring demand for the newer diabetes and weight ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Insulet Corporation ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its intention to offer, subject to market ...

Insulet Corporation (NASDAQ: PODD) has announced its plan to offer $450 million aggregate principal amount of senior ...

With little direct competition in patch pumps, Insulet has been able to convert more users, especially patients on multiple daily injections, to its innovative, tubeless insulin pump. The firm has ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Insulet Corporation (NASDAQ: PODD) (Insulet or the Compa ...

Feb 20(Reuters) - Insulet (PODD.O), opens new ... driven by strong demand for its wearable insulin pumps. The company produces and sells Omnipod, an automated insulin delivery device, which ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, will host an Investor Day at the Company's global headquarters in Acton ...